KR100455906B1 - 펠리누스 린테우스의 균사체를 추출 정제하여 얻은다당류를 유효성분으로 포함하는 폐암 치료용 약학적 조성물 - Google Patents
펠리누스 린테우스의 균사체를 추출 정제하여 얻은다당류를 유효성분으로 포함하는 폐암 치료용 약학적 조성물 Download PDFInfo
- Publication number
- KR100455906B1 KR100455906B1 KR10-2001-0066256A KR20010066256A KR100455906B1 KR 100455906 B1 KR100455906 B1 KR 100455906B1 KR 20010066256 A KR20010066256 A KR 20010066256A KR 100455906 B1 KR100455906 B1 KR 100455906B1
- Authority
- KR
- South Korea
- Prior art keywords
- mesima
- cells
- lung cancer
- cytotoxicity
- immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
구분 | 세포독성(IC50,㎍/㎖) | ||
A549 | L1210 | Ma104 | |
메시마 | >200 | >200 | >200 |
메시마 PL-2 | 140 | >200 | >200 |
구분 | 총세포수(x107) | 면역세포의 종류(%) | ||
PMN | 대식세포 | 기타 | ||
생리식염수 | 1.2±0.57 | 9.2±5.44 | 21.8±6.29 | 69.0±0.85 |
박토펩톤 | 5.5±0.85 | 68.3±0.14 | 8.5±0.85 | 23.2±0.71 |
NIH-티오글리코레이트 | 1.92±0.61 | 6.5 | 45.7 | 47.8 |
메시마 | 2.7±0.35 | 37.6±0.21 | 30.4±10.54 | 32.0±10.75 |
메시마 PL-2 | 4.4±0.36 | 52.0±11.24 | 34.9±9.91 | 13.1±2.33 |
Claims (2)
- 펠리누스 린테우스(Phellinus linteus) KCTC 0173BP와 KCTC 0399BP의 균사체를 추출 정제하여 얻은 분자량 153,000 달톤의 항암면역활성 다당류인 α(1,6)-헤테로글리칸(heteroglycan)과 갈락토만노글루칸(galactomannoglucan)을 유효성분으로 포함하는 것을 특징으로 하는 폐암 치료용 약학적 조성물.
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0066256A KR100455906B1 (ko) | 2001-10-26 | 2001-10-26 | 펠리누스 린테우스의 균사체를 추출 정제하여 얻은다당류를 유효성분으로 포함하는 폐암 치료용 약학적 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0066256A KR100455906B1 (ko) | 2001-10-26 | 2001-10-26 | 펠리누스 린테우스의 균사체를 추출 정제하여 얻은다당류를 유효성분으로 포함하는 폐암 치료용 약학적 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030034604A KR20030034604A (ko) | 2003-05-09 |
KR100455906B1 true KR100455906B1 (ko) | 2004-11-15 |
Family
ID=29566509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0066256A KR100455906B1 (ko) | 2001-10-26 | 2001-10-26 | 펠리누스 린테우스의 균사체를 추출 정제하여 얻은다당류를 유효성분으로 포함하는 폐암 치료용 약학적 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100455906B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100596827B1 (ko) * | 2003-04-02 | 2006-07-03 | 주식회사한국신약 | 홍삼 및 펠리누스 속 균주의 균사체에서 추출한 다당류를함유하는 기능성식품 |
CN105747068A (zh) * | 2016-03-29 | 2016-07-13 | 福建嘉田农业开发有限公司 | 一种深沉发酵的银耳芽孢、桑黄菌丝体混合饮品制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5796001A (en) * | 1980-12-06 | 1982-06-15 | Microbial Chem Res Found | Heteroglycan, its preparation and immune activator containing the same as an active ingredient |
JPH03175974A (ja) * | 1989-12-01 | 1991-07-31 | Seizo Yamana | 制癌作用のある菌糸体の培養方法 |
KR0174433B1 (ko) * | 1995-09-06 | 1999-02-18 | 김은영 | 펠리누스 린테우스로부터 분리된 항암 면역활성 다당류 및 이의 제조 방법 |
WO1999027802A1 (en) * | 1997-11-28 | 1999-06-10 | Han Kook Sin Yak Pharm. Co., Ltd. | HEALTH BEVERAGE CONTAINING THE EXTRACT OF $i(PHELLINUS LINTEUS) |
KR19990081594A (ko) * | 1998-04-30 | 1999-11-15 | 한만우 | 펠리누스 린테우스로부터 분리한 다당류 물질의신규한 용도 |
KR19990081593A (ko) * | 1998-04-30 | 1999-11-15 | 한만우 | 신규한 면역증강활성 다당류물질 및 그 제조방법 |
KR19990081595A (ko) * | 1998-04-30 | 1999-11-15 | 한만우 | 신규한 면역증강활성 물질을 생산하는 펠리누스속 균주 |
JP2001081047A (ja) * | 2000-08-09 | 2001-03-27 | Kyokuho Yagita | 経口摂取用製剤 |
-
2001
- 2001-10-26 KR KR10-2001-0066256A patent/KR100455906B1/ko active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5796001A (en) * | 1980-12-06 | 1982-06-15 | Microbial Chem Res Found | Heteroglycan, its preparation and immune activator containing the same as an active ingredient |
JPH03175974A (ja) * | 1989-12-01 | 1991-07-31 | Seizo Yamana | 制癌作用のある菌糸体の培養方法 |
KR0174433B1 (ko) * | 1995-09-06 | 1999-02-18 | 김은영 | 펠리누스 린테우스로부터 분리된 항암 면역활성 다당류 및 이의 제조 방법 |
WO1999027802A1 (en) * | 1997-11-28 | 1999-06-10 | Han Kook Sin Yak Pharm. Co., Ltd. | HEALTH BEVERAGE CONTAINING THE EXTRACT OF $i(PHELLINUS LINTEUS) |
KR19990081594A (ko) * | 1998-04-30 | 1999-11-15 | 한만우 | 펠리누스 린테우스로부터 분리한 다당류 물질의신규한 용도 |
KR19990081593A (ko) * | 1998-04-30 | 1999-11-15 | 한만우 | 신규한 면역증강활성 다당류물질 및 그 제조방법 |
KR19990081595A (ko) * | 1998-04-30 | 1999-11-15 | 한만우 | 신규한 면역증강활성 물질을 생산하는 펠리누스속 균주 |
JP2001081047A (ja) * | 2000-08-09 | 2001-03-27 | Kyokuho Yagita | 経口摂取用製剤 |
Also Published As
Publication number | Publication date |
---|---|
KR20030034604A (ko) | 2003-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Choromanska et al. | Anticancer properties of low molecular weight oat beta-glucan–An in vitro study | |
Wachtel-Galor et al. | Ganoderma lucidum (Lingzhi or Reishi): a medicinal mushroom | |
KR100955973B1 (ko) | 세포 사멸을 조절하는 세포독성인자 | |
Xie et al. | Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo | |
Wang et al. | The novel glycyrrhetinic acid–tetramethylpyrazine conjugate TOGA induces anti-hepatocarcinogenesis by inhibiting the effects of tumor-associated macrophages on tumor cells | |
KR101090505B1 (ko) | 난담반을 포함하는 암 예방 및 치료용 조성물 | |
JPH10130153A (ja) | 大腸癌、食道癌及び乳癌より選ばれた癌に用いる 抗悪性腫瘍剤 | |
KR100455906B1 (ko) | 펠리누스 린테우스의 균사체를 추출 정제하여 얻은다당류를 유효성분으로 포함하는 폐암 치료용 약학적 조성물 | |
CN104434939B (zh) | 三七皂苷r7和冬凌草甲素减毒增效抗肿瘤药物组合物及其应用 | |
CN105213366B (zh) | 藤黄酮化合物的医药用途及其药物组合物 | |
CN113694085A (zh) | 蛞蝓提取物在制备癌症化疗方案的联用药物中的应用 | |
KR101727056B1 (ko) | 암세포 증식 억제효과를 갖는 한약재 백미 추출물 및 그의 제조방법 | |
MXPA06006717A (es) | Agentes de combinacion de chp-gencitabina y su uso como agentes anti-tumorales, especialmente como agentes anti-metastatizacion. | |
Hong et al. | Novel drug isolated from mistletoe (1 E, 4 E)-1, 7-bis (4-hydroxyphenyl) hepta-1, 4-dien-3-one for potential treatment of various cancers: synthesis, pharmacokinetics and pharmacodynamics | |
CN114177180A (zh) | 依鲁替尼的药物组合物 | |
KR101070475B1 (ko) | 암세포 사멸 유도 효과를 갖는 아실아마이드 화합물 | |
EA002290B1 (ru) | Противоопухолевое средство | |
CN113181172B (zh) | 芝麻素在制备治疗和/或预防淋巴瘤产品中的应用 | |
CN110876802B (zh) | 一种抗癌症的药物组合物 | |
CN110693903B (zh) | 一种治疗急性单核细胞白血病的药物及三氧化二砷和双氢青蒿素的应用 | |
CN105963302A (zh) | 一种含egfr酪氨酸激酶的低剂量药物组合物及其在制备预防肿瘤转移药物中的应用 | |
CN105307666A (zh) | 菜蓟属的提取物及其用途 | |
CN102349943A (zh) | 核桃楸皮提取物及其制备方法 | |
KR101830809B1 (ko) | 수용성 진주분말을 유효성분으로 포함하는 면역증강용 조성물 | |
Huang et al. | In vivo antitumor activity of ZYD88, a Chinese herbal medicine in animal models with S180 sarcoma and Ehrlich tumor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120917 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20130829 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20141002 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150909 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20161006 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20171030 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180831 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20190822 Year of fee payment: 16 |